The American Society of Hematology released evidence-based guidelines for the treatment of DVT and PE in patients without cancer.
Healthcare providers should take steps now to ensure that the telehealth modalities they use are HIPAA compliant.
AHA issued Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
Lipid-lowering therapies are key to the prevention of cardiovascular (CV) events and CV-related mortality.
TTP is a rare disease that clinicians may not often treat; however, it is important to be aware of new developments for the treatment of this patient population.
Mechanistic and outcomes studies are warranted to elucidate the lipid paradox and CVD risk in rheumatoid arthritis (RA).
Patients with HFpEF have substantial exercise intolerance, which may be due to peripheral factors.
Abdominal aortic aneurysms are likely to be encountered in the primary care setting, making appropriate diagnosis and management indispensable.
PAH associated with CHD is linked to significant reductions in survival and quality of life, especially for patients progressing to Eisenmenger syndrome.
Antoine N. Saliba, MD, and colleagues summarized current literature surrounding the frequent complications that bring patients with thalassemia into the ED.